parkinson glutathione oxidative ipsc crispr Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 Treatment of Parkinson's Disease through
Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells PMC Induced Pluripotent Stem Cells (iPSCs) as a Regenerative Strategy for Parkinson's Disease: Opportunities and Challenges Cell Biochemistry and Biophysics Springer Nature Link Alpha synuclein determines ferroptosis sensitivity in dopaminergic neurons via modulation of ether phospholipid membrane composition: Cell Reports Using induced pluripotent stem cells for modeling Parkinson's disease CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




